Arkadios Wealth Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $975K | Sell |
11,761
-4,381
| -27% | -$363K | 0.03% | 576 |
|
|
2025
Q1 | $1.31M | Buy |
16,142
+9,675
| +150% | +$785K | 0.05% | 383 |
|
|
2024
Q4 | $582K | Sell |
6,467
-33,131
| -84% | -$2.98M | 0.03% | 490 |
|
|
2024
Q3 | $3.91M | Sell |
39,598
-1,593
| -4% | -$157K | 0.22% | 101 |
|
|
2024
Q2 | $3.82M | Buy |
41,191
+3,007
| +8% | +$279K | 0.26% | 81 |
|
|
2024
Q1 | $3.62M | Buy |
38,184
+31,681
| +487% | +$3.01M | 0.28% | 83 |
|
|
2023
Q4 | $581K | Sell |
6,503
-290
| -4% | -$25.9K | 0.05% | 331 |
|
|
2023
Q3 | $496K | Sell |
6,793
-665
| -9% | -$48.6K | 0.05% | 340 |
|
|
2023
Q2 | $621K | Sell |
7,458
-964
| -11% | -$80.2K | 0.07% | 262 |
|
|
2023
Q1 | $642K | Sell |
8,422
-740
| -8% | -$56.4K | 0.08% | 255 |
|
|
2022
Q4 | $760K | Buy |
9,162
+413
| +5% | +$34.3K | 0.1% | 207 |
|
|
2022
Q3 | $694K | Buy |
8,749
+3,317
| +61% | +$263K | 0.11% | 203 |
|
|
2022
Q2 | $403K | Buy |
+5,432
| New | +$403K | 0.06% | 334 |
|
|
2021
Q4 | – | Sell |
-256
| Closed | -$32K | – | 1791 |
|
|
2021
Q3 | $32K | Sell |
256
-260
| -50% | -$32.5K | ﹤0.01% | 1051 |
|
|
2021
Q2 | $69K | Buy |
516
+206
| +66% | +$27.5K | 0.01% | 830 |
|
|
2021
Q1 | $42K | Hold |
310
| – | – | 0.01% | 739 |
|
|
2020
Q4 | $43K | Buy |
310
+260
| +520% | +$36.1K | 0.01% | 585 |
|
|
2020
Q3 | $6.03K | Hold |
50
| – | – | ﹤0.01% | 824 |
|
|
2020
Q2 | $5.74K | Buy |
+50
| New | +$5.74K | ﹤0.01% | 766 |
|